Semiotic analysis of lovecraftian cosmic horror movies and an evaluation of horror genre in Turkish cinema
Bu tez size mi ait?
Bu kayıt toplu arşivden geldi. Sizinse profilinize bağlayın.
Özet (EN)
Cosmic Horror, developed by H. P. Lovecraft, is a subgenre of science fiction, fantasy and horror. Cosmic horror is about the fear of the unknowable. It is usually about threatening beings from outer space or ancient malevolent mysteries. It has also played a key role in the development of horror cinema. Unlike stereotypical horror themes, deep stories about the pains of human existence are included in the cosmic horror subgenre. This thesis presents a research on feature films that are directly or indirectly related to the cosmic horror genre. With this aim, some sample films were selected and some sequences of these films were analyzed using the semiotic method. Moreover, in order to make an evaluation on horror films in Turkish cinema, participants who have produced works in the horror genre were interviewed. They were asked to answer specific questions. A conclusion was finally reached based on the collected findings.
Yazar
Melih Önder
Bu Yayına Nasıl Atıf Yapılır
Melih Önder (Master Thesis). Semiotic analysis of lovecraftian cosmic horror movies and an evaluation of horror genre in Turkish cinema, 2023, Yeditepe University.
Lisans
Tüm Hakları Saklıdır
Bu eser belirtilen lisans koşulları altında paylaşılmaktadır.
Yeditepe University tezlerinden daha fazlası
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)